Geovax Labs Inc (GOVX): Next-Year EPS Estimate 64.69%
As of 2026-06-04, Geovax Labs Inc (GOVX) has a next-year EPS growth estimate of 64.69%.
GOVX was first flagged by our screen on 2026-05-26, when analyst consensus for its next-year EPS growth was revised from 54.63% to 64.69%. Current-year growth is projected at 61.18%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 64.69%
- EPS growth this year
- 61.18%
- EPS next quarter (est)
- -$2.15
- Last price
- $1.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 64.69% | 61.18% | -$2.15 | $1.79 |
| 2026-06-03 | 64.69% | 61.18% | -$2.15 | $2.03 |
| 2026-06-02 | 64.69% | 61.18% | -$2.15 | $2.10 |
| 2026-06-01 | 64.69% | 61.18% | -$2.15 | $2.21 |
| 2026-05-31 | 64.69% | 61.18% | -$2.15 | $2.06 |
| 2026-05-28 | 64.69% | 61.18% | -$2.62 | $2.40 |
| 2026-05-27 | 64.69% | 61.18% | -$2.62 | $2.67 |
| 2026-05-26 | 64.69% | 61.18% | -$2.62 | $3.49 |
| 2026-05-25 | 54.63% | 58.57% | -$2.62 | $3.64 |
| 2026-05-24 | 54.63% | 58.57% | -$2.62 | $3.64 |
| 2026-05-21 | 61.06% | 71.62% | -$1.80 | $2.75 |
| 2026-05-20 | 61.06% | 71.62% | -$1.80 | $2.23 |
| 2026-05-19 | 61.06% | 71.62% | -$1.80 | $2.01 |
| 2026-05-18 | 85.35% | 24.60% | -$3.84 | $2.21 |
| 2026-05-17 | 85.35% | 24.60% | -$3.84 | $1.23 |
| 2026-05-14 | 88.55% | 27.29% | -$3.50 | $1.26 |
| 2026-05-13 | 88.55% | 27.29% | -$3.50 | $1.28 |
| 2026-05-12 | 88.55% | 27.29% | -$3.50 | $1.37 |
| 2026-05-11 | 88.55% | 27.29% | -$3.50 | $1.48 |
| 2026-05-10 | 88.55% | 27.29% | -$3.50 | $1.67 |
| 2026-05-07 | 88.55% | 27.29% | -$3.50 | $1.76 |
| 2026-05-06 | 88.55% | 27.29% | -$3.50 | $1.65 |
| 2026-05-05 | 88.55% | 27.29% | -$3.50 | $1.42 |
| 2026-05-04 | 88.55% | 27.29% | -$3.50 | $1.27 |
| 2026-05-03 | 88.55% | 27.29% | -$3.50 | $1.15 |
| 2026-04-30 | 88.55% | 27.29% | -$3.50 | $1.09 |
| 2026-04-29 | 88.55% | 27.29% | -$3.50 | $1.05 |
| 2026-04-28 | 88.55% | 27.29% | -$3.50 | $1.10 |
| 2026-04-27 | 88.55% | 27.29% | -$3.50 | $1.11 |
| 2026-04-26 | 88.55% | 27.29% | -$3.50 | $1.09 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Geovax Labs Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Geovax Labs Inc (GOVX) has a next-year EPS growth estimate of 64.69%, based on analyst consensus.
When was the latest EPS estimate revision for GOVX?▾
The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 54.63% to 64.69%.
What sector and industry does Geovax Labs Inc belong to?▾
Geovax Labs Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GOVX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Geovax Labs Inc (GOVX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports